Dkk-1

Dkk-1

Dkk-1 Informations sur la molécule

Molecule Name
Dickkopf-related protein 1
Alias de la molécule
DKK1,SK
Drug Development Progress
Nombre de médicaments cliniques4
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
Dickkopf-Like Protein 1,Dickkopf 1 Homolog,Dickkopf-1 Like,Dickkopf-1,Dkk-1,UNQ492/PRO1008,Dickkopf-related protein 1,hDkk-1,SK,DKK1,Dickkopf WNT Signaling Pathway Inhibitor 1,Dickkopf 1 Homolog (Xenopus Laevis),Dickkopf (Xenopus Laevis) Homolog 1
Contexte de la molécule
Members of the dickkopf-related protein family (DKK-1, -2, -3, and -4) are secreted proteins with two cysteine-rich domains separated by a linker region. And DKK1 takes part in embryonic development through its inhibition of the WNT signaling pathway, binds to LRP6 with high affinity and prevents the Frizzled-Wnt-LRP6 complex formation in response to Wnts. DKK1 promotes LRP6 internalization and degradation when it forms a ternary complex with the cell surface receptor Kremen.DKK1 not olny functions as a head inducer during development, but also regulates joint remodeling and bone formation, which suggests roles for DKK1 in the pathogenesis of rheumatoid arthritis and multiple myeloma. More recently research reported, DKK1 impacts eye development from a defined developmental time point on, and is critical for lens separation from the surface ectoderm via β-catenin mediated Pdgfrα and E-cadherin expression.

Dkk-1 Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
JS-015JS-015Phase 2 ClinicalShanghai Junshi Biological Engineering Co Ltd
Colorectal Neoplasms; Neoplasms; Solid tumours
Details
AGA-2115AGA2115; AGA-2115Phase 2 ClinicalAngitia Biopharmaceuticals (Guangzhou) Ltd
Osteogenesis Imperfecta
Details
AGA-2118AGA-2118Phase 2 ClinicalAngitia Biomedicines Ltd
Osteoporosis; Osteoporosis, Postmenopausal
Details
SirexatamabDKN-01; LY-2812176Phase 2 ClinicalEli Lilly And Company
Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinosarcoma; Cholangiocarcinoma; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Liver Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Uterine Neoplasms
Details